BioCentury
ARTICLE | Finance

Enthera’s €28M series A latest sign of growth for Italy’s biotech ecosystem

Autoimmune play Enthera first biotech to emerge from Italy’s BiovelocITA accelerator

July 29, 2020 1:33 AM UTC

U.S. and European investors are backing the largest-ever series A financing for an Italian biotech, autoimmune play Enthera s.r.l.

Enthera raised €28 million ($32.8 million) in the round, which was led by existing investor Sofinnova Partners and new investor AbbVie Ventures. ...